Project Number ADDF-26 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2020 View Full Project Details for Phase I Clinical Trial for the AAV mediated treatment of APOE4 homozygous Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator Crystal, Ronald Principal Investigator First Name Ronald Principal Investigator Last Name Crystal Awardee Organization Lexeo Therapeutics, Inc. Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Clinical Trial Program FY Overall Cost $1,997,865 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management
